“Controversial ‘Female Viagra’ Hits the Market, New Questions Arise”

1
160

Despite concerns about the drug’s necessity, effectiveness, and side-effects, Flibanserin (Addyi) has come to market as the first drug designed to increase sexual desire in women.  Many are concerned that the drug will be prescribed “off-label,” in populations that the drug was not approved to treat.  This could have serious consequences as taking flibanserin with alcohol, oral contraception, or other medications can significantly increase the risk of side-effects.

Article →

1 COMMENT

LEAVE A REPLY